# Protalix BioTherapeutics, Inc.: Form 8-K, filed Jul 21, 2025

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2025-07-21
- Accepted by EDGAR: Jul 21, 2025, 13:27 ET
- Period: 2025-06-13
- Accession: 0001558370-25-009308
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837025009308/plx-20250613x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837025009308/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837025009308/plx-20250613x8k.htm

Filed Jul 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-009308. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.